The Role of Protein Aggregation in Pharmaceutical Drug Development
American Journal of Pharmaceutics · 2025-07-21 · 6 (2) · 1-14
DOI: 10.71465/ajph2737 ↗At a glance
Journal article in American Journal of Pharmaceutics, published online on 2025-07-21. Written by Dr. Amina Rauf. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Protein aggregation presents a significant challenge in the pharmaceutical drug development process, particularly for biologics and protein-based therapeutics. These aggregates can negatively impact drug efficacy, stability, and safety. This article explores the underlying mechanisms of protein aggregation, factors influencing it, and strategies to mitigate its effects during drug development. The study also discusses analytical methods for detecting aggregates and regulatory perspectives on aggregate control. Understanding and controlling protein aggregation is critical for enhancing drug formulation, storage, and delivery, ultimately leading to improved therapeutic outcomes.
Cite
APA
Rauf, D. A. (2025). The Role of Protein Aggregation in Pharmaceutical Drug Development. American Journal of Pharmaceutics, 6(2), 1-14. https://doi.org/10.71465/ajph2737
Vancouver
Rauf DA. The Role of Protein Aggregation in Pharmaceutical Drug Development. American Journal of Pharmaceutics. 2025;6(2):1-14. doi:10.71465/ajph2737
BibTeX
@article{Rauf2025,
author = {Rauf, Dr. Amina},
title = {The Role of Protein Aggregation in Pharmaceutical Drug Development},
journal = {American Journal of Pharmaceutics},
year = {2025},
volume = {6},
number = {2},
pages = {1--14},
doi = {10.71465/ajph2737}
}
EUVIMED